Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PLC Systems -- Ignore unavailable to you. Want to Upgrade?

To: Tokyo VD who wrote (660)	4/24/1998 12:29:00 PM
From: K.C.	Read Replies (1) \| Respond to of 1202

I'm getting the same info! Supposedly the FDA has done an about face on this! The FDA researcher is indicating that the longer term data is implying that there is less chance that TMR's relief is psychological in nature (ergo:it seems to really work). Also, one of the medical reviewers, Dr. Boyce a heart surgeon at Washington Hosp. Center is quoted as saying that TMR "highly efficacious". It's about time we started getting some good news!

To: Tokyo VD who wrote (660)	4/24/1998 2:52:00 PM
From: Rob C.	Read Replies (2) \| Respond to of 1202

Tokyo, Anymore updates?? Please post progress reports. Thanks in advance, Rob

To: Tokyo VD who wrote (660)	4/24/1998 7:15:00 PM
From: Steve H.	Respond to of 1202

I'm sorry to see that you are harbouring a grudge, Tokyo. In fact, I find it frustrating to see people (anyone) posting opinions as fact without a source to back up their statements. I'm pleased to see you are changing your style to include the source of your statements - it helps us all make better decisions based on facts. May I suggest we (Tokyo, JF and I) turn our attention to this term "conditional approval" and determine what effect that may have on actual FDA approval. I don't have any experience with this stuff. You may have more information on this, Tokyo. Is that term used whenever an advisory panel delivers a positive result? Do you think it is something to be concerned about? Also, any idea on the time frame (or date) for the FDA to either adopt or reject the advisory panel's decision?